Differential effects of human immunodeficiency virus isolates on β- chemokine and gamma interferon production and on cell proliferation

Journal of Virology

Volumn 73, Issue 2, 1999, Pages 1528-1534

  Greco, Giampaolo ^a,b   Fujimura, Sue H ^a   Mourich, Dan V ^a   Levy, Jay A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CD4 ANTIGEN; GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERFERON PRODUCTION; MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNCYTIUM; T LYMPHOCYTE SUBPOPULATION; VIRUS ISOLATION;

EID: 0032935037     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.2.1528-1534.1999     Document Type: Article

References (39)

1. Berger, E. A. 1997. HIV entry and tropism: the chemokine receptor connection. AIDS 11:s3-s16.
2. Bjorndal, A., H. Deng, M. Jansson, J. R. Fiore, C. Colognesi, A. Karlsson, J. Albert, G. Scarlatti, D. R. Littman, and E. M. Fenyo. 1997. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J. Virol. 71:7478-7487.
3. Blazevic, V., M. Heino, A. Ranki, T. Jussila, and K. J. E. Krohn. 1996. RANTES, MIP and interleukin-16 in HIV infection. AIDS 10:1435-1436.
4. Broder, C. C., and R. G. Collman. 1997. Chemokine receptors and HIV. J. Leukocyte Biol. 62:20-29.
5. Buonaguro, L., G. Barillari, H. K. Chang, C. A. Bohan, V. Kao, R. Morgan, R. C. Gallo, and B. Ensoli. 1992. Effects of the human immunodeficiency virus type 1 tat protein on the expression of inflammatory cytokines. J. Virol. 66:7159-7167.
6. Castro, B. A., C. D. Weiss, L. D. Wiviott, and J. A. Levy. 1988. Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells. J. Clin. Microbiol. 26:2371-2376.
7. Cheng-Mayer, C., D. Seto, M. Tateno, and J. A. Levy. 1988. Biologic features of HIV that correlate with virulence in the host. Science 240:80-82.
8. Clerici, M., C. Balotta, D. Trabattoni, L. Papagno, S. Ruzzante, S. Rusconi, M. L. Fusi, M. C. Colombo, and M. Galli. 1996. Chemokine production in HIV-seropositive long-term asymptomatic individuals. AIDS 10:1432-1433.
9. Clerici, M., and G. M. Shearer. 1994. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today 15:575-581.
10. + T cells. Science 270:1811-1815.
11. Connor, R. I., K. E. Sheridan, D. Ceradini, S. Choe, and N. R. Landau. 1997. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185:621-628.
12. Cook, D. N., M. A. Beck, T. M. Coffman, S. L. Kirby, J. F. Sheridan, I. B. Prganell, and O. Smithies. 1995. Requirement of MIP-1α for an inflammatory response to viral infection. Science 269:1583-1585.
13. Gessani, S., P. Borghi, L. Fantuzzi, B. Varano, L. Conti, P. Puddu, and F. Belardelli. 1997. Induction of cytokines by HIV-1 and its gp120 protein in human peripheral blood monocyte/macrophages and modulation of cytokine response during differentiation. J. Leukocyte Biol. 62:49-53.
14. Gong, W., O. M. Howard, J. A. Turpin, M. C. Grimm, H. Ueda, P. W. Gray, C. J. Raport, J. J. Oppenheim, and J. M. Wang. 1998. Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/ replication. J. Biol. Chem. 273:4289-4292.
15. + lymphocytes are not related to β-chemokine production. AIDS Res. Hum. Retroviruses 14: 1407-1411.
16. Huffman, A. D., B. Banapour, and J. A. Levy. 1985. Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology 147:326-335.
17. Kaminsky, L. S., T. McHugh, D. Stites, P. Volberding, G. Henle, W. Henle, and J. A. Levy. 1985. High prevalence of antibodies to AIDS-associated retroviruses (ARV) in acquired immune deficiency syndrome and related conditions and not in other disease states. Proc. Natl. Acad. Sci. USA 82:5535-5539.
18. Koot, M., A. H. V. Vos, R. P. M. Keet, R. E. Y. de Goede, M. W. Dercksen, F. G. Terpstra, R. A. Coutinho, F. Miedema, and M. Tersmette. 1992. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 6:49-54.
19. + T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin. Immunol. Immunopathol. 69:106-116.
20. Levy, J. A. 1998. HIV and the pathogenesis of AIDS, 2nd ed. American Society for Microbiology, Washington, D.C.
21. Levy, J. A., A. D. Hoffman, S. M. Kramer, J. A. Landis, J. M. Shimabukuro, and L. S. Oshiro. 1984. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225:840-842.
22. + cells. Immunol. Today 17:217-224.
23. Levy, J. A., L. H. Tobler, T. M. McHugh, C. H. Casavant, and D. P. Stites. 1985. Long-term cultivation of T cell subsets from patients with acquired immune deficiency syndrome. Clin. Immunol. Immunopathol. 35:328-3.16.
24. Mackewicz, C. E., E. Barker, G. Greco, G. Reyes-Teran, and J. A. Levy. 1997. Do β-chemokines have clinical relevance in HIV infection? J. Clin. Invest. 100:921-930.
25. Mackewicz, C. E., E. Barker, and J. A. Levy. 1996. Role of β-chemokines in suppressing HIV replication. Science 274:1393-1395.
26. + cell anti-HIV activity correlates with the clinical state of the infected individual. J. Clin. Invest. 87:1462-1466.
27. Margolick, J. B., D. J. Volkman, T. M. Folks, and A. S. Fauci. 1987. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses. J. Immunol. 138:1719-1723.
28. McDougal, J. S., S. P. Cort, M. S. Kennedy, C. D. Cabridilla, P. M. Feorino, D. P. Francis, D. Hicks, V. S. Kalyanaraman, and L. S. Martin. 1985. Immunoassay for the detection and quantitation of infectious human retro-virus, lymphadenopathy-associated virus (LAV). J. Immunol. Methods 76: 171-183.
29. Merrill, J. E., Y. Koyanagi, and I. S. Y. Chen. 1989. Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J. Virol. 63:4404-4408.
30. Neon, L. P., H. Akimoto, H. Kaneko, T. Hishikawa, H. Hashimoto, S. Hirose, Y. Kaneko, N. Yamamoto, and I. Sekigawa. 1997. The production of betachemokines induced by HIV-2 envelope glycoprotein. AIDS 11:1062-1063.
31. Ott, M., S. Emiliani, C. Van Lint, G. Herbein, J. Lovett, N. Chirmule, T. W. McCloskey, S. Pahwa, and E. Verdin. 1997. Immune hyperactivation of HIV-1 infected T cells mediated by tat and the CD28 pathway. Science 275:1481-1485.
32. +. T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro J. Virol. 72:876-881.
33. Schmidtmayerova, H., H. S. L. Nottet, G. Nuovo, T. Raabe, C. R. Flanagan, L. Dubrovsky, H. E. Gendleman, A. Cerami, M. Bukrinsky, and B. Sherry. 1996. Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc. Natl. Acad. Sci. USA 93:700-704.
34. Schrum, S., P. Probst, B. Fleischer, and P. F. Zipfel. 1996. Synthesis of the CC-chemokines MIP-1α, MIP-1β, and RANTES is associated with a type 1 immune response. J. Immunol. 157:3598-3604.
35. Tersmette, M., R. E. Y. de Goede, B. J. M. Al, I. N. Winkel, R. A. Gruters, H. T. Cuypers, H. G. Huisman, and F. Miedema. 1988. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 62:2026-2032.
36. Tersmette, M., R. A. Gruters, F. de Wolf, R. E. Y. de Goede, J. M. A. Lange, P. T. A. Schellekens, J. Goudsmit, H. G. Huisman, and F. Miedema. 1989. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J. Virol. 63:2118-2125.
37. Trkola, A., W. A. Paxton, S. P. Monard, J. A. Hoxie, M. A. Siani, D. A. Thompson, L. Wu, C. R. Mackay, R. Horuk, and J. P. Moore. 1998. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines. J. Virol. 72:396-404.
38. Ullum. H., A. Cozzi Lepri, J. Victor, H. Aladdin, A. N. Phillips, J. Gerstoft, P. Skinhoj, and B. K. Pedersen. 1998. Induction of beta-chemokines in human immunodeficiency virus (HIV) infection: evidence that high levels of macrophage inflammatory protein 1-beta are associated with a decreased risk of HIV disease progression. J. Infect. Dis. 177:331-336.
39. Wong, M., and E. N. Fish. 1998. RANTES and MIP-1 alpha activate stats in T cells. J. Biol. Chem. 273:309-314.